You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antidepressant drug

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pharmacogenetics of Antidepressant-Induced Disinhibition

Recruiting
  • Obsessive-Compulsive Disorder
  • +3 more
    • Calgary, Alberta, Canada
      Child and Adolescent Addiction, Mental Health & Psychiatry
    Nov 4, 2022

    Depression, Anxiety, Generalized Anxiety Disorder Trial in Tampa (DNA-guided choice of therapy, Clinical management)

    Active, not recruiting
    • Depression
    • +5 more
    • DNA-guided choice of therapy
    • Clinical management
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Mar 23, 2022

    Dyspepsia, Functional Gastrointestinal Disorders, Antidepressant Discontinuation Syndrome Trial in Shanghai (Deanxit)

    Recruiting
    • Dyspepsia
    • +3 more
    • Shanghai, China
      Shengliang Chen
    Mar 17, 2022

    Neonatal Hypotonia Associated With in Utero Exposure to

    Active, not recruiting
    • Neonatal Hypotonia
    • +2 more
    • Caen, Normandy, France
      Caen University Hospital
    Mar 31, 2021

    MDD Trial in Seoul (tDCS treatment, Antidepressant Drug(escitalopram))

    Completed
    • Major Depressive Disorder
    • tDCS treatment
    • Antidepressant Drug(escitalopram)
    • Seoul, Korea, Republic of
      Seoul St. Mary's Hospital, The Catholic University of Korea
    Sep 8, 2020

    Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)

    Completed
    Has Results
    • Depressive Disorder, Major
    • Phoenix, Arizona
    • +49 more
    Jul 20, 2022

    MDD Trial in Worldwide (Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg, Antidepressant + SPD489 (Lisdexamfetamine

    Completed
    Has Results
    • Major Depressive Disorder
    • Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg
    • +4 more
    • Little Rock, Arkansas
    • +81 more
    May 25, 2021

    MDD, Chronic Major Depression, Recurrent Trial in Austin (Sertraline)

    Not yet recruiting
    • Major Depressive Disorder
    • Chronic Major Depression, Recurrent
    • Austin, Texas
      Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z060
    May 26, 2023

    Implementation of Personalized Medicine for Optimal Drug Therapy

    Not yet recruiting
    • Nausea With Vomiting Chemotherapy-Induced
    • +2 more
    • Pharmacogenetic testing
    • Drug-Drug interaction analysis
    • London, Ontario, Canada
      Lawson Health Research Institute
    Apr 13, 2023

    MDD, Treatment-Resistant Depression, Depression Trial run by the NIMH (Placebo, TS-161 (50 - 100 mg))

    Recruiting
    • Major Depressive Disorder
    • +2 more
    • Placebo
    • TS-161 (50 - 100 mg)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    MDD Trial in Gwangju (stepwise pharamacotherapy, antidepressant monotherapy group)

    Recruiting
    • Major Depressive Disorder
    • stepwise pharamacotherapy
    • antidepressant monotherapy group
    • Gwangju, Korea, Republic of
      Chonnam National University Hospital
    Sep 19, 2023

    Drug-resistant Psychiatric Disorders Using Induced Pluripotent

    Enrolling by invitation
    • Depressive Disorder, Treatment-Resistant
      • Monza, Monza E Brianza, Italy
        Fondazione IRCCS San Gerardo di Monza
      May 24, 2023

      MDD, Anhedonia Trial in Saint Louis (Psilocybin)

      Withdrawn
      • Major Depressive Disorder
      • Anhedonia
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jan 26, 2023

      Depression Trial (Fecal microbiota transplantation(FMT), Placebo)

      Not yet recruiting
      • Depression
      • Fecal microbiota transplantation(FMT)
      • Placebo
      • (no location specified)
      May 6, 2023

      MDD Trial in Phoenix, Yuma, Okeechobee (ALTO-300, Placebo)

      Recruiting
      • Major Depressive Disorder
      • Phoenix, Arizona
      • +2 more
      Jun 19, 2023

      Depression Trial in Paris (MAP4343, Placebo)

      Recruiting
      • Depression
      • Paris, France
        APHP La Pitié Salpétrière
      Nov 10, 2022

      Depression in Adolescence Trial in Calgary (Pharmacogenetic-guided dosing, GLAD-PC guided dosing)

      Not yet recruiting
      • Depression in Adolescence
      • Pharmacogenetic-guided dosing
      • GLAD-PC guided dosing
      • Calgary, Alberta, Canada
        University of Calgary
      Jul 25, 2023

      Treatment Resistant Depression Trial in Klecany (Psilocybin, Ketamine Hydrochloride, Midazolam Ph. Eur 9.0)

      Recruiting
      • Treatment Resistant Depression
      • Klecany, Czechia
        National Institute of Mental Health
      May 16, 2022

      Efficacy, Team, Adverse Reaction to Drug Trial in Chongqing (Sertraline)

      Completed
      • Efficacy, Team
      • Adverse Reaction to Drug
      • Chongqing, Chongqing, China
        The First Affiliated Hospital of Chongqing Medical University
      Nov 8, 2023

      MDD Trial in United States (REL-1017, Placebo)

      Recruiting
      • Major Depressive Disorder
      • Saraland, Alabama
      • +46 more
      Jan 18, 2023

      Female Sexual Arousal Disorder Trial in Austin (Caffeine)

      Not yet recruiting
      • Female Sexual Arousal Disorder
      • Austin, Texas
        The University of Texas at Austin, Sexual Psychophysiology Labor
      Jan 5, 2023

      Depressive Disorder, Major Trial in Worldwide (Seltorexant, Matching to Seltorexant, Quetiapine XR)

      Recruiting
      • Depressive Disorder, Major
      • Birmingham, Alabama
      • +212 more
      Jul 20, 2022

      Treatment Resistant Depression, Depression, MDD Trial in Oxford (Ketamine Hydrochloride, No intervention ())

      Recruiting
      • Treatment Resistant Depression
      • +2 more
      • Ketamine Hydrochloride
      • No intervention (placebo)
      • Oxford, United Kingdom
        Department of Psychiatry, University of Oxford
      Mar 28, 2023

      MDD Trial in St Leonards (Esketamine Nasal Spray [Spravato])

      Not yet recruiting
      • Major Depressive Disorder
      • Esketamine Nasal Spray [Spravato]
      • St Leonards, New South Wales, Australia
        Royal North Shore Hospital
      Oct 22, 2023

      Depression, Depressive Disorder Trial in Bhopal (Healthy Activity Program (HAP), Antidepressant medication (ADM))

      Recruiting
      • Depression
      • Depressive Disorder
      • Healthy Activity Program (HAP)
      • Antidepressant medication (ADM)
      • Bhopal, Madhya Pradesh, India
        Sangath
      Nov 22, 2023